BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1416813)

  • 1. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies.
    Lindsey JW; Albers GW; Steinman L
    Ann Neurol; 1992 Sep; 32(3):407-9. PubMed ID: 1416813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Ikeda K; Araki Y; Iwasaki Y
    Neurology; 2007 Apr; 68(16):1326; author reply 1327. PubMed ID: 17441229
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis and scleroderma.
    Bhalla R; Swedler WI; Lazarevic MB; Ajmani HS; Skosey JL
    J Rheumatol; 1993 Aug; 20(8):1409-10. PubMed ID: 8230029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
    Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
    Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid disorders associated with myasthenia gravis].
    Lucas Martín A
    Med Clin (Barc); 1987 Nov; 89(16):684-8. PubMed ID: 3320602
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent transverse myelitis after lumbar spine surgery: a case report.
    Banit DM; Wheeler AH; Darden BV
    Spine (Phila Pa 1976); 2003 May; 28(9):E165-8. PubMed ID: 12942019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Kister I; Herbert J; Swerdlow ML; Bergamaschi R; Piccolo G; Oger J
    Neurology; 2007 Apr; 68(16):1326-7; author reply 1327. PubMed ID: 17441230
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier.
    Matsui M; Kakigi R; Watanabe S; Kuroda Y
    J Neurol Sci; 1996 Aug; 139(2):235-7. PubMed ID: 8856658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Gotkine M; Fellig Y; Abramsky O
    Neurology; 2006 Sep; 67(5):881-3. PubMed ID: 16966558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Associated myasthenia and disseminated lupus erythematosus. A report on two cases and complete review of the published literature (author's transl)].
    Mizon JP; Morcamp D; Lefebvre P; Froissart M; Guidicelli CP; Goasguen J
    Ann Med Interne (Paris); 1979; 130(11):489-500. PubMed ID: 317696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.
    Lavalle C; Pizarro S; Drenkard C; Sánchez-Guerrero J; Alarcón-Segovia D
    J Rheumatol; 1990 Jan; 17(1):34-7. PubMed ID: 2313670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.
    Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarström L; Pirskanen R; Piehl F
    J Intern Med; 2015 May; 277(5):594-604. PubMed ID: 25251578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual association of insulin-dependent diabetes mellitus with congenital myasthenia gravis and autoimmune thyroid disease.
    Karp M; Kott E; Shapira M; Assa S; Brautbar C; Gurewitz R; Laron Z
    Isr J Med Sci; 1984 Nov; 20(11):1078-81. PubMed ID: 6511337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA).
    Harada T; Ohashi T; Harada C; Yoshida K; Maguchi S; Moriwaka F; Matsuda H
    J Neuroophthalmol; 1997 Dec; 17(4):254-6. PubMed ID: 9427178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors in myasthenia gravis: a family study.
    Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
    Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.